Surgical Treatment of Giant Cavernous Hepatic Haemangiomas

Ibrahim Abdelkader Salama, Mohammed Hussein Abdullah, Mohammed Houseni

Department of Anesthesia, National Liver Institute, Menophyia University.Shiben Elkom, Egypt.
Department of Hepatobilary Surgery, National Liver Institute, Menophyia University.Shiben Elkom, Egypt.
Department of Radiology, National Liver Institute, Menophyia University.Shiben Elkom, Egypt.

DOI: 10.4236/ss.2012.38081                

Abstract

Background: Haemangiomas are the most common benign liver tumors. Treatment is indicated for symptomatic tumors, rapid increase in size, rupture or doubt in diagnosis. Objective: Evaluation the efficacy of surgical treatment of giant cavernous hepatic haemangioma in tertiary hepatobiliary center. Patients and Methods: Retrospective study of 34 patients with giant hepatic haemangioma operated upon. The diagnosis was proved preoperatively in 27 patients and confirmed by histopathology postoperatively in all patients. The indication of surgery was abdominal pain with large sizes tumors, rapid growth, and spontaneous rupture with haemoperitoneum. Surgical treatment either liver resection or living liver transplantation. Results: 23 cases (67.6%) were females & 11 cases (32.4%) were males, median age 38.8 years. Haemangiomas located in right lobe in 19 patients (55.9%), left lobe in 12 patients (35.4%) in both lobe in 2 patients (5.8%), scattered all over both lobe in one patient (2.9%), solitary in 27 cases (79.4%) and multiple in 7 patients (20.6%). The diameter was 8 - 27 cm, mean 18.6 cm in diameter. 33 patients had liver resection (29 elective resection and 4 emergent resection for rupture). One patient had haemangioma irresectable; the living liver transplant was performed. No mortality during 18 months follow up and complication occurred in 8 patients out of 34 patients. Conclusion: Hepatic resection is an effective treatment option for giant cavernous hepatic haemangioma, in selected patient living related liver transplantation may be the only therapeutic option.

Keywords

Liver Neoplasms; Haemangioma; Hepatectomy

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	M. A. M. Brouwers, K. P. De Jong, E. B. Haagstmast, J. Klampmakert, M. A. Bijleveidt, J. H. Zwaveling and M. J. H. Sloot, “Surgical Treatment of Giant Haemangioma of the Liver,” British Journal of Surgery, Vol. 84, No. 3, 1997, pp. 314-316.
[2]	F. C. Nicholis, J. A. Van Heerden and L. H. Weiland, “Benign Liver Tumors,” The Surgical Clinics of North America, Vol. 69, No. 2, 1989, pp. 297-314.
[3]	R. Gedaly, J. J. Pomposelli, E. A. Pomfret, W. D. Lewis and R. L. Jenkins, “Cavernous Haemangioma of the Liver,” Archives of Surgery, Vol. 134, 1999, 407-411.
[4]	O. Nishida, N. Satoh, A. S. Alam and J. Chino, “The Effect of Hepatic Artery Ligation for Irresectable Cavernous Haemangioma of the Liver,” The American Surgeon, Vol. 54, No. 8, 1988, pp. 483-486.
[5]	K. Tepetes, R. Selby, M. Webb, J. R. Madariaga, S. Iwatsuki and T. E. Starzl, “Orthotopic Liver Transplantation for Benign Hepatic Neoplasm,” Archives of Surgery, Vol. 130, No. 2, 1995, pp. 153-156.
[6]	K. G. Ishak and L. Rabin, “Benign Tumors of the Liver,” Medical Clinics of North America, Vol. 59, 1975, pp. 995-1013.
[7]	Y. Cui, L. Y. Zhou, M. K. Dong, et al., “Ultrasonography Guided Percutaneous Radiofrequency Ablation for Hepatic Cavernous Haemangima,” World Journal of Gastroenterlogy, Vol. 9, No. 9, 2003, pp. 2132-2134.
[8]	T. Motohara, R. C. Semelka and L. Ragase, “MR Imaging of Benign Hepatic Tumors,” Magnetic Resonance Imaging Clinics of North America, Vol. 10, No. 1, 2002, 1-14. doi:10.1016/S1064-9689(03)00046-1
[9]	G. S. Deutsch, K. A. Yen, W. B. Bales, et al., “Embolization for Management of Hepatic Haemangiomas,” The American Surgeon, Vol. 67, No. 2, 2001, pp. 159-164.
[10]	S. N. Hochwald and L. H. Blungart, “Giant Haemangiomas with Kasabach-Merritt Syndrome: Is the appropriate treatment enculation or liver transplantation?” HPB Surgery, Vol. 11, No. 6, 2000, pp. 413-419. doi:10.1155/2000/25954
[11]	Y. Kumashiro, M. Kasahara, K. Nomoto, M. Kawai, K. Sasaki, T. Kiuchi and K. Tanaka, “Living Donor Liver Transplantation for Giant Hepatic Haemangioma with Kasabach-Merritt Syndrome with a Posterior Segment Graft,” Liver Transplantation, Vol. 8, No. 8, 2002, pp. 721-724. doi:10.1053/jlts.2002.33689
[12]	P. J. Mego and P. R. Ros, “Benign Lesions of the Liver,” Radiologic Clinics of North America, Vol. 36, No. 2, 1998, pp. 319-331.
[13]	A. Cappellani, A. Zanghi, M. Divita, G. Zanghi, G. Tomarchio and G. Petrill, “Spontaneous Rupture of a Giant Haemangioma of the Liver,” Annali Italiani Di Chirurgia, Vol. 71, No. 3, 2000, pp. 379-383.
[14]	N. Coriglian, P. Mercantini, P. M. Amodio, G. Balducci, S. Caterino, G. Ramacciato, et al., “Hemoperitoneum from a Spontaneous Rupture of a Giant Heamangioma of Liver: Report of a Case,” Surgery Today, Vol. 33, No. 6, 2003, pp. 459-463. doi:10.1007/s10595-002-2514-z
[15]	S. Warmann, H. Bertram, R. Kardorff, M. Sasse, F. G. Hausdor and J. Fuchs, “Interventional Treatment of Infantile Hepatic Haemangioendothelioma,” Journal of Pediatric Surgery, Vol. 38, No. 8, 2003, pp. 1177-1181. doi:10.1016/S0022-3468(03)00325-7
[16]	Q. L. Zeng, Y. H. Li, Y. Chen, Y. Ouyang, X. He and H. Zhang, “Gigantic Cavernous Haemangioma of the Liver Treated by Intra-Arterial Embolization with Pingyangmycin-Lipiodol Emulsion: A Multicentric Study,” Cardiovascular and Interventional Radiology, Vol. 27, No. 5, 2004, pp. 481-485.
[17]	I. Ozden, A. Emre, A. Alper, M. Tunci, K. Acarli, O. Bilge, Y. Tekanty and O. Ariogul, “Long-Term Results of Surgery after Haemangiomas,” Archives of Surgery, Vol. 135, No. 8, 2000, pp. 978-981. doi:10.1001/archsurg.135.8.978
[18]	E. J. Yun, B. I. Choi, J. K. Han, et al., “Hepatic Haemangioma: Contrast-Enhanced Pattern during the Arterial and Portal Venous Phases of Special CT,” Abdominal Imaging, Vol. 24, No. 3, 1999, pp. 262-266.
[19]	T. Motohara, R. C. Semelka and L. Nagase, “MR Imaging of Benign Hepatic Tumors,” Magnetic Resonance Imaging Clinics of North America, Vol. 10, No. 1, 2002, pp. 1-14.
[20]	B. A. Birnabaum, J. C. Weinreb and A. J. Megibow, “Definitive Diagnosis of Hepatic Haemangiomas: MR Imaging Versus Tc-99m-Labelled RBC,” Radiology, Vol. 126, 1990, pp. 95-101.
[21]	T. Kerkivatan, W. W. Vrijland, P. T. Den Hoed, R. A. De Man, S. M. Hussain, H. W. Tilanus, et al., “Size of Lesion in Not a Criterion for Resection during Management of Giant Liver Haemangioma,” British Journal of Surgery, Vol. 89, No. 10, 2002, pp. 1240-1244. doi:10.1046/j.1365-2168.2002.02219.x
[22]	T. Terkivatan, J. H. Dewilt, R. A. Deman, R. R. Van Rijn, P. E. Zondervan, H. W. Tilanus, et al., “Indication and Long-Term Outcome of Treatment for Benign Hepatic Tumors: A Critical Appraisal,” Archives of Surgery, Vol. 136, 2001, pp. 1033-1038. doi:10.1001/archsurg.136.9.1033
[23]	H. P. Tsai, L. B. Jerg, W. C. Lee and M. F. Chen, “Clinical Experience of Hepatic Haemangioma Undergoing Hepatic Resection,” Digestive Diseases and Sciences, Vol. 48, No. 5, 2003, pp. 916-920.
[24]	S. I. Schwatz and W. C. Husser, “Cavernous Haemangioma of the Liver; A Single Institution Report of 16 Resections,” Annals of Surgery, Vol. 205, 1987, pp. 456-465. doi:10.1097/00000658-198705000-00003
[25]	P. Peveretos and D. Panoussopoul, “Giant Cavernous Hepatic Haemangioma: Treatment by Ligation of the Hepatic Artery,” Journal of Surgical Oncology, Vol. 31, No. 1, 1986, pp. 48-51. doi:10.1002/jso.2930310111
[26]	I. Popescu, S. Ciuraa, V. Brasveanu, et al., “Liver Haemangioma Revisited: Currant Surgical Indication, Technical Aspects, Results,” Hepatogastroenterology, Vol. 48, No. 39, 2001, pp. 770-776.
[27]	S. S. Yoon, C. K. Charny, Y. Fong, W. R. Jamagin, L. H. Schwartz, L. T. Blumgart, et al., “Diagnosis, Manamgement, and Outcome of 115 Patients with Hepatic Haemangioma,” Journal of the American College of Surgeons, Vol. 197, No. 3, 2003, pp. 392-402. doi:10.1016/S1072-7515(03)00420-4
[28]	A. Pietrabissa, P. Giulianotti, A. Campatelli, G. Di Candio, F. Farina, S. Signori, et al., “Management and Follow-Up of 78 Giant Haemangiomas of the Liver,” British Journal of Surgery, Vol. 83, No. 7, 1996, pp. 915-918. doi:10.1002/bjs.1800830710
[29]	A. E. Moreno, M. R. Del Pozo, M. C. Vicente and J. A. Abellan, “Indications for Surgery in the Treatment of Hepatic Haemangioma,” Hepatogastroenterology, Vol. 43, No. 8, 1998, pp. 422-426.
[30]	N. Corigliano, P. Mercantini, P. M. Amodio, G. Balducci, S. Caterino, G. Ramacciato, et al., “Haemoperitoneum from a Spontaneous Rupture of a Giant Haemangioma of the Liver: Report of a Case,” Surgery Today, Vol. 33, No. 6, 2003, pp. 459-463. doi:10.1007/s10595-002-2514-z
[31]	V. Haefen, Inaugural Dissertation, Wurzbung, 1898.
[32]	J. H. Sewell and K. Weiss, “Spontaneous Rupture of Haemangioma of the Liver. A Review of the Literature and Presentation of Illustrative Case,” Archives of Surgery, Vol. 83, No. 7, 1961, pp. 29-33.
[33]	H. Imamura, Y. Seyama, N. Kokudo, et al., “One Thousand Fifty-Six Hepatectomy without Mortality in 8 Years,” Archives of Surgery, Vol. 138, No. 11, 2003, pp. 1198-1206. doi:10.1001/archsurg.138.11.1198